ALK Fusion-positive Solid or CNS Tumors
2 clinical trials · Condition
◉ Watch ALK Fusion-positive Solid or CNS Tumors
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors (NCT04774718) | Hoffmann-La Roche | 2021-09-14 |
Track ALK Fusion-positive Solid or CNS Tumors automatically
Every clearance here is in the API, with alerts when new ones post.